The correct way to take imatinib mesylate (Gleevec) tablets

Imatinib mesylate (Imatinib), trade name Gleevec, is an oral small molecule tyrosine kinase inhibitor that is widely used in the treatment of chronic myeloid leukemia (CML), gastrointestinal stromal tumor (GIST) and certain other malignant tumors. The correct way of taking the drug is crucial to ensure the efficacy of the drug and reduce adverse reactions. The following is a detailed introduction to the correct way to take imatinib mesylate tablets, including dosage adjustment, medication time, precautions and suggestions for handling common problems.

First of all, imatinib mesylate tablets are generally recommended for oral administration, and patients should take them according to the prescribed dosage under the guidance of a doctor. A common standard dose is once daily, usually with breakfast, but this can be adjusted based on your doctor's advice. When taking the medicine, you should swallow it with an appropriate amount of water and avoid chewing or crushing the tablets to ensure the sustained release effect and stable efficacy of the medicine. It is generally recommended that patients take medicine at a fixed time every day to maintain stable blood drug concentration, thereby improving the therapeutic effect.

Secondly, regarding dosage, the specific dosage of imatinib varies depending on the type of disease and patient status. For patients in the chronic phase of chronic myeloid leukemia, the recommended starting dose is 400 once a day; for patients in the blast crisis or myeloid crisis phase, the dose can be increased to 600 to 800mg once a day. The recommended dose for patients with gastrointestinal stromal tumors is usually 400 mg once daily. During the treatment process, the doctor will adjust the dosage based on the patient's tolerance and efficacy. Do not change the dosage on your own to avoid reduced efficacy or serious side effects caused by improper dosage.

In terms of medication time, imatinib can be taken before or after meals, but in clinical practice, most patients choose to take it after meals to reduce gastrointestinal discomfort. If gastrointestinal reactions such as nausea and diarrhea occur, you can try taking the medicine after meals or in small amounts in divided doses to reduce symptoms. At the same time, you should avoid taking gastric acid inhibitors (such as proton pump inhibitors) or antacids containing calcium and magnesium at the same time, because these drugs may affect the absorption and blood concentration of imatinib, affecting its efficacy. When combined use is necessary, the medication intervals should be reasonably arranged as directed by the doctor.

In addition, while taking imatinib, patients should undergo regular hematology tests and liver function monitoring to detect potential side effects in a timely manner, such as bone marrow suppression, abnormal liver function, etc. If serious adverse reactions occur, the doctor may temporarily stop the medication or adjust the dose. Patients should strictly abide by the follow-up schedule and not stop medication at will or add medication on their own. At the same time, if you plan to become pregnant or are breastfeeding, you should inform your doctor, because imatinib may have an impact on the fetus, and you need to weigh the pros and cons to formulate a medication plan.

In daily life, patients should avoid taking imatinib at the same time with certain drugs, such as certain antifungals, antibiotics, etc. These drugs may affect the metabolism of imatinib and change its blood concentration by inhibiting or inducing the liver enzyme system. If you need to use other drugs together, you should inform your doctor in advance to ensure the safety of the medication. In terms of diet, maintaining balanced nutrition and avoiding heavy drinking can help reduce the burden of drugs on the liver.

In short, the correct way to take imatinib mesylate includes taking it regularly and quantitatively as directed by your doctor, avoiding arbitrary changes in dosage and discontinuation of medication, paying attention to the medication time and interactions with other drugs, and monitoring your physical condition with regular examinations. If patients experience abnormal symptoms during medication, they should communicate with their doctor in time. Through scientific and reasonable medication management, the therapeutic effect of imatinib can be maximized and the patient's quality of life and treatment prognosis can be improved.

Reference materials:https://www.gleevec.com/